Company Name, Ticker, Customers, else..

Best Performing Stocks In Medical Equipment & Supplies Industry During This Month Of April

1 Day

Week

Current Month of April

30 Days

Current Quarter Q2 of 2025

90 Days

Ytd

12 Months

Shares improved by 0.86% on average, in Medical Equipment & Supplies Industry during this month of April.

Here are the best performing stocks in Medical Equipment & Supplies Industry.

TIVC

$7.12

$4.6000

182.54%
This Month of April

TIVC

$7.12

$4.6000

182.54%

Tivic Health Systems Inc

Tivic Health Systems Inc stock improved 182.54% during this month of April.

Tivic Health Systems Inc is a company that operates on a direct-to-consumer business model. They develop and sell at-home medical devices for various health conditions, providing customers with the convenience of accessing healthcare solutions from the comfort of their own homes. By cutting out intermediaries and selling directly to consumers, Tivic Health Systems aims to deliver their products more efficiently and establish a direct relationship with their customers.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 0.120 mill.	$ 0.780 mill.	$ -5.655 mill.	0 mill.	-	Y/Y -49.58 %

Market Cap.	Revenues TTM	Net Income TTM
$ 0.120 mill.	$ 0.780 mill.	$ -5.655 mill.
Employees	Shares Outstanding	P/E
16	0 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -49.58 %	MRQ Y/Y - %

SNOA

$4.23

$2.0600

94.93%
This Month of April

SNOA

$4.23

$2.0600

94.93%

Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals Inc shares improved 94.93% during this month of April.

Sonoma Pharmaceuticals Inc operates as a healthcare company that specializes in developing and manufacturing innovative products for various dermatological conditions. They focus on commercializing and distributing advanced solutions for wound care, dermatoses, and other skin disorders, aiming to provide effective treatment options to patients and healthcare professionals.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 6.193 mill.	$ 13.973 mill.	$ -3.748 mill.	1 mill.	-	Y/Y 13.58 %

Market Cap.	Revenues TTM	Net Income TTM
$ 6.193 mill.	$ 13.973 mill.	$ -3.748 mill.
Employees	Shares Outstanding	P/E
36	1 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 13.58 %	MRQ Y/Y - %

MBOT

$2.61

$1.1200

75.17%
This Month of April

MBOT

$2.61

$1.1200

75.17%

Microbot Medical Inc

Microbot Medical Inc stock went up 75.17% during this month of April.

Microbot Medical Inc is a medical device company that focuses on the research, development, and commercialization of surgical solutions. Their business model revolves around creating innovative robotic technologies and tools for minimally invasive surgeries, catering to various medical specialties.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 40.913 mill.	$ - mill.	$ -11.443 mill.	16 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 40.913 mill.	$ - mill.	$ -11.443 mill.
Employees	Shares Outstanding	P/E
21	16 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

ATPC

$2.21

$0.9400

74.02%
This Month of April

ATPC

$2.21

$0.9400

74.02%

Agape Atp Corporation

Agape Atp Corporation shares increased 74.02% during this month of April.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 8.666 mill.	$ 1.323 mill.	$ -2.486 mill.	4 mill.	-	Y/Y -72.80 %

Market Cap.	Revenues TTM	Net Income TTM
$ 8.666 mill.	$ 1.323 mill.	$ -2.486 mill.
Employees	Shares Outstanding	P/E
-	4 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -72.80 %	MRQ Y/Y - %

NAOV

$5.15

$2.1000

68.85%
This Month of April

NAOV

$5.15

$2.1000

68.85%

Nanovibronix Inc

Nanovibronix Inc shares went up 68.85% during this month of April.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 1.390 mill.	$ 2.508 mill.	$ -3.705 mill.	0 mill.	-	Y/Y -13.97 %

Market Cap.	Revenues TTM	Net Income TTM
$ 1.390 mill.	$ 2.508 mill.	$ -3.705 mill.
Employees	Shares Outstanding	P/E
51	0 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -13.97 %	MRQ Y/Y - %

BSGM

$0.92

$0.3650

65.77%
This Month of April

BSGM

$0.92

$0.3650

65.77%

Biosig Technologies Inc

Biosig Technologies Inc stock went up 65.77% during this month of April.

Biosig Technologies Inc is a medical device company that specializes in innovative solutions for the healthcare industry. Their business model revolves around developing and commercializing proprietary technologies, particularly in the field of physiological signal monitoring. By creating and marketing advanced medical devices, Biosig aims to improve patient outcomes and provide healthcare professionals with valuable tools for better diagnostics and treatment.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 14.905 mill.	$ - mill.	$ 7.844 mill.	16 mill.	0.63	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 14.905 mill.	$ - mill.	$ 7.844 mill.
Employees	Shares Outstanding	P/E
56	16 mill.	0.63
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

ICAD

$3.28

$1.3000

65.66%
This Month of April

ICAD

$3.28

$1.3000

65.66%

Icad Inc

Icad Inc stock increased 65.66% during this month of April.

Icad Inc operates on a business model that focuses on the development and commercialization of innovative cancer detection and therapy solutions. They primarily generate revenue through the sale of their advanced medical devices and software solutions to hospitals, clinics, and research institutions worldwide. Their business strategy revolves around continuous innovation, strategic partnerships, and a commitment to providing effective tools for early detection and treatment of cancer.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 87.717 mill.	$ 18.635 mill.	$ -5.616 mill.	27 mill.	-	Y/Y 179.81 %

Market Cap.	Revenues TTM	Net Income TTM
$ 87.717 mill.	$ 18.635 mill.	$ -5.616 mill.
Employees	Shares Outstanding	P/E
66	27 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 179.81 %	MRQ Y/Y - %

SPAI

$3.27

$1.2350

60.69%
This Month of April

SPAI

$3.27

$1.2350

60.69%

Safe Pro Group Inc

Safe Pro Group Inc shares went up 60.69% during this month of April.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 34.702 mill.	$ 4.075 mill.	$ -14.857 mill.	11 mill.	-	Y/Y -24.58 %

Market Cap.	Revenues TTM	Net Income TTM
$ 34.702 mill.	$ 4.075 mill.	$ -14.857 mill.
Employees	Shares Outstanding	P/E
-	11 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -24.58 %	MRQ Y/Y - %

ADGM

$1.3

$0.4600

54.76%
This Month of April

ADGM

$1.3

$0.4600

54.76%

Adagio Medical Holdings inc

Adagio Medical Holdings Inc stock improved 54.76% during this month of April.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 0.988 mill.	$ 0.600 mill.	$ -73.180 mill.	1 mill.	-	Y/Y -83.66 %

Market Cap.	Revenues TTM	Net Income TTM
$ 0.988 mill.	$ 0.600 mill.	$ -73.180 mill.
Employees	Shares Outstanding	P/E
-	1 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -83.66 %	MRQ Y/Y - %

SGHT

$3.22

$0.9300

40.61%
This Month of April

SGHT

$3.22

$0.9300

40.61%

Sight Sciences Inc

Sight Sciences Inc stock went up 40.61% during this month of April.

Sight Sciences Inc operates using a business model focused on developing and commercializing innovative medical devices and technologies for the treatment of ophthalmic diseases. They aim to improve patient outcomes and provide value to healthcare providers by constantly advancing their product portfolio and expanding their reach in the ophthalmology market.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 161.022 mill.	$ 79.285 mill.	$ -51.507 mill.	50 mill.	-	Y/Y 3.34 %

Market Cap.	Revenues TTM	Net Income TTM
$ 161.022 mill.	$ 79.285 mill.	$ -51.507 mill.
Employees	Shares Outstanding	P/E
333	50 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 3.34 %	MRQ Y/Y - %

TMDX

$93.5

$25.2300

36.96%
This Month of April

TMDX

$93.5

$25.2300

36.96%

Transmedics Group Inc

Transmedics Group Inc shares went up 36.96% during this month of April.

Transmedics Group Inc operates on a business model focused on medical technology. They develop and commercialize portable systems to facilitate the transplantation of organs and tissues. Their innovative platforms provide organ preservation, transportation, and monitoring solutions, aiming to improve patient outcomes in organ transplantation procedures.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 3,283.053 mill.	$ 441.540 mill.	$ 35.464 mill.	35 mill.	93.58	Y/Y 49.83 %

Market Cap.	Revenues TTM	Net Income TTM
$ 3,283.053 mill.	$ 441.540 mill.	$ 35.464 mill.
Employees	Shares Outstanding	P/E
194	35 mill.	93.58
Revenue Growth	Income Growth
MRQ Y/Y 49.83 %	MRQ Y/Y 70.11 %

DRIO

$0.8

$0.2098

35.55%
This Month of April

DRIO

$0.8

$0.2098

35.55%

Dariohealth Corp

Dariohealth Corp shares increased 35.55% during this month of April.

DarioHealth Corp*s business model revolves around providing digital health solutions to individuals with chronic diseases. Through their mobile health platform, they offer personalized tools and remote monitoring capabilities that empower patients to proactively manage their conditions. By combining software, data analytics, and medical devices, DarioHealth aims to enhance patient engagement, improve health outcomes, and reduce healthcare costs.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 56.062 mill.	$ 26.267 mill.	$ 42.747 mill.	70 mill.	1.26	Y/Y 93.72 %

Market Cap.	Revenues TTM	Net Income TTM
$ 56.062 mill.	$ 26.267 mill.	$ 42.747 mill.
Employees	Shares Outstanding	P/E
190	70 mill.	1.26
Revenue Growth	Income Growth
MRQ Y/Y 93.72 %	MRQ Y/Y -32.57 %

RBOT

$8.47

$2.0900

32.76%
This Month of April

RBOT

$8.47

$2.0900

32.76%

Vicarious Surgical Inc

Vicarious Surgical Inc shares increased 32.76% during this month of April.

Vicarious Surgical Inc utilizes a business model that combines robotics and virtual reality to revolutionize surgical procedures. Their technology allows surgeons to perform minimally invasive surgeries with precision and control using robotic arms guided by a virtual reality interface. By offering an innovative solution to traditional surgical methods, Vicarious Surgical aims to enhance patient outcomes while minimizing the invasiveness and risks associated with traditional procedures.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 49.724 mill.	$ - mill.	$ -62.706 mill.	6 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 49.724 mill.	$ - mill.	$ -62.706 mill.
Employees	Shares Outstanding	P/E
123	6 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

WGS

$111.01

$26.4200

31.23%
This Month of April

WGS

$111.01

$26.4200

31.23%

Genedx Holdings Corp

Genedx Holdings Corp shares increased 31.23% during this month of April.

Genedx Holdings Corp operates as a genetic testing company, offering molecular and biochemical testing services for various genetic disorders and diseases. The company generates revenue by providing testing services to medical professionals and institutions around the world, aiding in accurate diagnosis and treatment planning for patients.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 2,991.891 mill.	$ 305.397 mill.	$ -52.286 mill.	27 mill.	-	Y/Y 66.30 %

Market Cap.	Revenues TTM	Net Income TTM
$ 2,991.891 mill.	$ 305.397 mill.	$ -52.286 mill.
Employees	Shares Outstanding	P/E
202	27 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 66.30 %	MRQ Y/Y - %

GTHP

$0.1088

$0.0252

30.14%
This Month of April

GTHP

$0.1088

$0.0252

30.14%

Guided Therapeutics Inc

Guided Therapeutics Inc stock increased 30.14% during this month of April.

Guided Therapeutics Inc operates on a business model focused on developing and commercializing medical devices for the early detection and monitoring of diseases, with a particular emphasis on cervical cancer.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 5.638 mill.	$ 0.007 mill.	$ -2.417 mill.	52 mill.	-	Y/Y -96.88 %

Market Cap.	Revenues TTM	Net Income TTM
$ 5.638 mill.	$ 0.007 mill.	$ -2.417 mill.
Employees	Shares Outstanding	P/E
11	52 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -96.88 %	MRQ Y/Y - %

AONC

$6.49

$1.4900

29.80%
This Month of April

AONC

$6.49

$1.4900

29.80%

American Oncology Network Inc

American Oncology Network Inc stock improved 29.80% during this month of April.

American Oncology Network Inc is a healthcare services company that operates as a physician-led organization, providing comprehensive, community-based oncology care across the United States. They partner with oncologists, hospitals, and practices to deliver high-quality, value-based cancer care while focusing on patient-centric solutions.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 28.972 mill.	$ 1,759.484 mill.	$ -26.958 mill.	4 mill.	-	Y/Y -47.94 %

Market Cap.	Revenues TTM	Net Income TTM
$ 28.972 mill.	$ 1,759.484 mill.	$ -26.958 mill.
Employees	Shares Outstanding	P/E
300	4 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -47.94 %	MRQ Y/Y - %

ECGI

$0.0014

$0.0003

27.27%
This Month of April

ECGI

$0.0014

$0.0003

27.27%

Event Cardio Group Inc.

Event Cardio Group Inc. shares improved 27.27% during this month of April.

Event Cardio Group Inc. operates on a revenue sharing model by providing mobile cardiac telemetry (MCT) monitoring services to healthcare providers. The company partners with cardiology practices, hospitals, and research institutions, offering their MCT devices for use in detecting arrhythmias and monitoring heart patients remotely. They generate income by charging a percentage of the reimbursement received by healthcare providers for the MCT services provided.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 0.188 mill.	$ - mill.	$ -1.900 mill.	134 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 0.188 mill.	$ - mill.	$ -1.900 mill.
Employees	Shares Outstanding	P/E
1	134 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

PDEX

$64.89

$13.4900

26.25%
This Month of April

PDEX

$64.89

$13.4900

26.25%

Pro dex Inc

Pro Dex Inc shares went up 26.25% during this month of April.

Pro dex Inc is a company that operates using a direct sales business model, selling their products directly to customers without the need for intermediaries. Their revenue is generated through the sales of their medical device components, primarily to original equipment manufacturers (OEMs) in the medical and dental industries. Pro dex Inc focuses on providing high-quality products and establishing long-term relationships with their customers to drive growth and profitability.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 216.560 mill.	$ 61.003 mill.	$ 6.748 mill.	3 mill.	32.40	Y/Y 33.40 %

Market Cap.	Revenues TTM	Net Income TTM
$ 216.560 mill.	$ 61.003 mill.	$ 6.748 mill.
Employees	Shares Outstanding	P/E
223	3 mill.	32.40
Revenue Growth	Income Growth
MRQ Y/Y 33.40 %	MRQ Y/Y 308.00 %

RCEL

$10.07

$1.9000

23.26%
This Month of April

RCEL

$10.07

$1.9000

23.26%

Avita Medical Inc

Avita Medical Inc stock increased 23.26% during this month of April.

Avita Medical Inc is a medical technology company that specializes in regenerative medicine. Their business model focuses on developing and commercializing innovative products for the treatment of burns, chronic wounds, and other skin-related conditions.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 260.577 mill.	$ 64.251 mill.	$ -61.845 mill.	26 mill.	-	Y/Y 29.67 %

Market Cap.	Revenues TTM	Net Income TTM
$ 260.577 mill.	$ 64.251 mill.	$ -61.845 mill.
Employees	Shares Outstanding	P/E
52	26 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 29.67 %	MRQ Y/Y - %

IRIX

$1.22

$0.2292

23.13%
This Month of April

IRIX

$1.22

$0.2292

23.13%

Iridex Corp

Iridex Corp stock went up 23.13% during this month of April.

Iridex Corp*s business model revolves around providing advanced medical devices and solutions for the treatment of eye conditions, primarily focused on ophthalmology.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 20.130 mill.	$ 48.502 mill.	$ -8.910 mill.	17 mill.	-	Y/Y -2.15 %

Market Cap.	Revenues TTM	Net Income TTM
$ 20.130 mill.	$ 48.502 mill.	$ -8.910 mill.
Employees	Shares Outstanding	P/E
205	17 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -2.15 %	MRQ Y/Y - %

ATAO

$0.049

$0.0090

22.50%
This Month of April

ATAO

$0.049

$0.0090

22.50%

Altair International Corp

Altair International Corp stock increased 22.50% during this month of April.

Altair International Corp is a diversified company with a business model focused on providing a range of products and services. Their offerings span various sectors, including technology, finance, health, and real estate. By leveraging their expertise and network, Altair International Corp aims to capitalize on opportunities and generate revenue through strategic investments, partnerships, and market expansion.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 1.607 mill.	$ - mill.	$ -0.258 mill.	33 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 1.607 mill.	$ - mill.	$ -0.258 mill.
Employees	Shares Outstanding	P/E
10	33 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

ECOR

$7.57

$1.3800

22.29%
This Month of April

ECOR

$7.57

$1.3800

22.29%

Electrocore Inc

Electrocore Inc stock increased 22.29% during this month of April.

Electrocore Inc operates on a business model that focuses on developing and commercializing innovative neuromodulation therapies. They utilize non-invasive vagus nerve stimulation (nVNS) to offer patients drug-free solutions for various medical conditions. The company*s approach involves leveraging their understanding of the human body*s electrochemical signaling system to provide targeted and effective treatments across multiple therapeutic areas.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 56.589 mill.	$ 24.397 mill.	$ -11.886 mill.	7 mill.	-	Y/Y 44.20 %

Market Cap.	Revenues TTM	Net Income TTM
$ 56.589 mill.	$ 24.397 mill.	$ -11.886 mill.
Employees	Shares Outstanding	P/E
27	7 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 44.20 %	MRQ Y/Y - %

CATX

$2.39

$0.4300

21.94%
This Month of April

CATX

$2.39

$0.4300

21.94%

Perspective Therapeutics Inc

Perspective Therapeutics Inc shares improved 21.94% during this month of April.

Perspective Therapeutics Inc is a biopharmaceutical company that focuses on developing innovative therapeutic solutions. Their business model involves conducting extensive research and development to create novel drug candidates targeting specific diseases. They aim to collaborate with pharmaceutical companies and seek partnerships to further develop and commercialize their products, ultimately making a positive impact on patients* lives.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 154.046 mill.	$ 1.454 mill.	$ 2.097 mill.	64 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 154.046 mill.	$ 1.454 mill.	$ 2.097 mill.
Employees	Shares Outstanding	P/E
21	64 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y 228.04 %

BTCY

$0.46

$0.0800

21.05%
This Month of April

BTCY

$0.46

$0.0800

21.05%

Biotricity Inc

Biotricity Inc stock improved 21.05% during this month of April.

The business model of Biotricity Inc focuses on providing medical technology solutions through the development and commercialization of innovative biomedical devices and services. The company leverages its expertise in remote patient monitoring, data analytics, and artificial intelligence to deliver personalized healthcare solutions to both patients and healthcare professionals. Biotricity Inc aims to improve patient outcomes, reduce healthcare costs, and enhance the overall efficiency of the healthcare system.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 11.147 mill.	$ 13.095 mill.	$ -12.896 mill.	24 mill.	-	Y/Y 21.73 %

Market Cap.	Revenues TTM	Net Income TTM
$ 11.147 mill.	$ 13.095 mill.	$ -12.896 mill.
Employees	Shares Outstanding	P/E
15	24 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 21.73 %	MRQ Y/Y - %

ZJYL

$0.8957

$0.1529

20.58%
This Month of April

ZJYL

$0.8957

$0.1529

20.58%

Jin Medical International Ltd

Jin Medical International Ltd stock went up 20.58% during this month of April.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 6.500 mill.	$ 19.821 mill.	$ 2.878 mill.	7 mill.	2.24	Y/Y 0.00 %

Market Cap.	Revenues TTM	Net Income TTM
$ 6.500 mill.	$ 19.821 mill.	$ 2.878 mill.
Employees	Shares Outstanding	P/E
-	7 mill.	2.24
Revenue Growth	Income Growth
MRQ Y/Y 0.00 %	MRQ Y/Y 0.00 %

AMIX

$2.08

$0.3500

20.23%
This Month of April

AMIX

$2.08

$0.3500

20.23%

Autonomix Medical Inc

Autonomix Medical Inc stock went up 20.23% during this month of April.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 3.852 mill.	$ - mill.	$ -5.105 mill.	2 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 3.852 mill.	$ - mill.	$ -5.105 mill.
Employees	Shares Outstanding	P/E
-	2 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

STIM

$4.48

$0.7000

18.52%
This Month of April

STIM

$4.48

$0.7000

18.52%

Neuronetics inc

Neuronetics Inc shares improved 18.52% during this month of April.

Neuronetics Inc is a medical device company focused on developing and commercializing non-invasive brain stimulation therapies for psychiatric disorders. Their business model primarily revolves around manufacturing and selling their flagship product, the NeuroStar Advanced Therapy System, which is used for the treatment of major depressive disorder. They generate revenue through the device sales, along with providing support services and maintenance to the healthcare facilities implementing their technology.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 141.893 mill.	$ 74.161 mill.	$ -43.727 mill.	32 mill.	-	Y/Y 10.99 %

Market Cap.	Revenues TTM	Net Income TTM
$ 141.893 mill.	$ 74.161 mill.	$ -43.727 mill.
Employees	Shares Outstanding	P/E
122	32 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 10.99 %	MRQ Y/Y - %

TALK

$3.12

$0.4600

17.29%
This Month of April

TALK

$3.12

$0.4600

17.29%

Talkspace Inc

Talkspace Inc shares improved 17.29% during this month of April.

Talkspace Inc is an online therapy platform that connects users with licensed therapists through a messaging app.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 358.176 mill.	$ 186.836 mill.	$ 1.148 mill.	115 mill.	517.65	Y/Y 16.41 %

Market Cap.	Revenues TTM	Net Income TTM
$ 358.176 mill.	$ 186.836 mill.	$ 1.148 mill.
Employees	Shares Outstanding	P/E
521	115 mill.	517.65
Revenue Growth	Income Growth
MRQ Y/Y 16.41 %	MRQ Y/Y - %

HSCS

$3.1986

$0.4486

16.31%
This Month of April

HSCS

$3.1986

$0.4486

16.31%

Heartsciences Inc

Heartsciences Inc shares improved 16.31% during this month of April.

Heart Test Laboratories Inc operates as a medical diagnostic company that specializes in heart testing. Their business model revolves around providing innovative and accurate cardiovascular diagnostic tests to healthcare facilities and patients, aimed at early detection and prevention of heart diseases. They achieve this by leveraging advanced technology, collaborating with medical professionals, and offering their services through partnerships with hospitals, clinics, and physicians.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 3.154 mill.	$ - mill.	$ -8.517 mill.	1 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 3.154 mill.	$ - mill.	$ -8.517 mill.
Employees	Shares Outstanding	P/E
-	1 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

ALGN

$183.35

$25.2700

15.99%
This Month of April

ALGN

$183.35

$25.2700

15.99%

Align Technology inc

Align Technology Inc shares went up 15.99% during this month of April.

Align Technology Inc. employs a direct-to-consumer business model centered around its Invisalign clear aligners, which are marketed through licensed orthodontists and general practitioners. The company also operates a comprehensive digital platform that allows healthcare professionals to submit patient cases for treatment planning and to monitor patient progress throughout their orthodontic journey.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 13,746.748 mill.	$ 3,998.159 mill.	$ 421.362 mill.	75 mill.	32.65	Y/Y 4.07 %

Market Cap.	Revenues TTM	Net Income TTM
$ 13,746.748 mill.	$ 3,998.159 mill.	$ 421.362 mill.
Employees	Shares Outstanding	P/E
21,610	75 mill.	32.65
Revenue Growth	Income Growth
MRQ Y/Y 4.07 %	MRQ Y/Y -16.29 %

NRXS

$2.44

$0.3300

15.64%
This Month of April

NRXS

$2.44

$0.3300

15.64%

Neuraxis Inc

Neuraxis Inc shares went up 15.64% during this month of April.

Neuraxis Inc is a medical technology company that specializes in developing advanced neuroscience solutions. Their business model revolves around creating innovative products and services for the diagnosis and treatment of neurological disorders, aiming to improve patient outcomes and enhance healthcare practices in the field of neurology.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 16.906 mill.	$ 2.686 mill.	$ -8.242 mill.	7 mill.	-	Y/Y -43.05 %

Market Cap.	Revenues TTM	Net Income TTM
$ 16.906 mill.	$ 2.686 mill.	$ -8.242 mill.
Employees	Shares Outstanding	P/E
-	7 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -43.05 %	MRQ Y/Y - %

STXS

$1.97

$0.2600

15.20%
This Month of April

STXS

$1.97

$0.2600

15.20%

Stereotaxis Inc

Stereotaxis Inc stock went up 15.20% during this month of April.

Stereotaxis Inc*s business model involves developing and providing robotic technologies for use in medical procedures, particularly in the field of electrophysiology.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 166.485 mill.	$ 26.594 mill.	$ -24.045 mill.	85 mill.	-	Y/Y 61.50 %

Market Cap.	Revenues TTM	Net Income TTM
$ 166.485 mill.	$ 26.594 mill.	$ -24.045 mill.
Employees	Shares Outstanding	P/E
139	85 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 61.50 %	MRQ Y/Y - %

ATEC

$11.51

$1.4300

14.19%
This Month of April

ATEC

$11.51

$1.4300

14.19%

Alphatec Holdings Inc

Alphatec Holdings Inc stock improved 14.19% during this month of April.

Alphatec Holdings Inc is a medical technology company that develops and manufactures surgical solutions and implants for spine surgery.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 1,651.359 mill.	$ 611.262 mill.	$ -162.123 mill.	143 mill.	-	Y/Y 28.94 %

Market Cap.	Revenues TTM	Net Income TTM
$ 1,651.359 mill.	$ 611.262 mill.	$ -162.123 mill.
Employees	Shares Outstanding	P/E
839	143 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 28.94 %	MRQ Y/Y - %

KDLY

$1.81

$0.2200

13.84%
This Month of April

KDLY

$1.81

$0.2200

13.84%

Kindly Md Inc

Kindly Md Inc shares improved 13.84% during this month of April.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 9.773 mill.	$ 2.720 mill.	$ -3.618 mill.	5 mill.	-	Y/Y -77.80 %

Market Cap.	Revenues TTM	Net Income TTM
$ 9.773 mill.	$ 2.720 mill.	$ -3.618 mill.
Employees	Shares Outstanding	P/E
-	5 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -77.80 %	MRQ Y/Y - %

GUTS

$1.26

$0.1500

13.51%
This Month of April

GUTS

$1.26

$0.1500

13.51%

Fractyl Health Inc

Fractyl Health Inc stock improved 13.51% during this month of April.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 54.780 mill.	$ 0.093 mill.	$ -68.694 mill.	43 mill.	-	Y/Y -96.77 %

Market Cap.	Revenues TTM	Net Income TTM
$ 54.780 mill.	$ 0.093 mill.	$ -68.694 mill.
Employees	Shares Outstanding	P/E
79	43 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -96.77 %	MRQ Y/Y - %

COCH

$1.48

$0.1700

12.98%
This Month of April

COCH

$1.48

$0.1700

12.98%

Anzu Special Acquisition Corp I

Anzu Special Acquisition Corp I shares improved 12.98% during this month of April.

Envoy Medical Inc is a medical device company that develops and sells innovative solutions for individuals with hearing loss, including their flagship product - the Esteem? Hearing Implant. Their business model revolves around designing, manufacturing, and distributing these implantable devices to healthcare providers, ensuring quality patient care and accessibility to those in need of hearing restoration.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 27.785 mill.	$ 0.225 mill.	$ -22.452 mill.	19 mill.	-	Y/Y -47.50 %

Market Cap.	Revenues TTM	Net Income TTM
$ 27.785 mill.	$ 0.225 mill.	$ -22.452 mill.
Employees	Shares Outstanding	P/E
10	19 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -47.50 %	MRQ Y/Y - %

PLSE

$17.91

$1.9700

12.36%
This Month of April

PLSE

$17.91

$1.9700

12.36%

Pulse Biosciences Inc

Pulse Biosciences Inc shares improved 12.36% during this month of April.

Pulse Biosciences Inc*s business model focuses on the development and commercialization of proprietary technology platforms, specifically in the field of nano-pulse stimulation (NPS) technology.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 1,043.160 mill.	$ - mill.	$ -53.585 mill.	58 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 1,043.160 mill.	$ - mill.	$ -53.585 mill.
Employees	Shares Outstanding	P/E
32	58 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

CLPT

$14.7

$1.6100

12.30%
This Month of April

CLPT

$14.7

$1.6100

12.30%

Clearpoint Neuro Inc

Clearpoint Neuro Inc shares increased 12.30% during this month of April.

Clearpoint Neuro Inc*s business model revolves around providing advanced deep brain stimulation (DBS) solutions for the treatment of neurological disorders. It focuses on developing and commercializing innovative medical devices, software, and services that enable precise and accurate targeting for electrode placement during neurosurgical procedures.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 397.194 mill.	$ 31.390 mill.	$ -18.914 mill.	27 mill.	-	Y/Y 14.11 %

Market Cap.	Revenues TTM	Net Income TTM
$ 397.194 mill.	$ 31.390 mill.	$ -18.914 mill.
Employees	Shares Outstanding	P/E
107	27 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 14.11 %	MRQ Y/Y - %

NEPH

$2.01

$0.2000

11.05%
This Month of April

NEPH

$2.01

$0.2000

11.05%

Nephros Inc

Nephros Inc stock increased 11.05% during this month of April.

Nephros Inc operates under a business model focused on developing and marketing specialty medical products and technologies for renal disease patients. The company aims to provide innovative filtration and purification solutions to improve the quality of life for individuals with renal disorders.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 14.874 mill.	$ 13.723 mill.	$ 0.074 mill.	7 mill.	1,049.84	Y/Y 30.28 %

Market Cap.	Revenues TTM	Net Income TTM
$ 14.874 mill.	$ 13.723 mill.	$ 0.074 mill.
Employees	Shares Outstanding	P/E
31	7 mill.	1,049.84
Revenue Growth	Income Growth
MRQ Y/Y 30.28 %	MRQ Y/Y - %

PEN

$299.78

$28.6500

10.57%
This Month of April

PEN

$299.78

$28.6500

10.57%

Penumbra Inc

Penumbra Inc stock increased 10.57% during this month of April.

Penumbra Inc operates on a business model that focuses on the development and manufacturing of innovative medical devices. They aim to provide cutting-edge technologies and solutions to improve patient outcomes in various medical fields. The company primarily generates revenue through the sales of their medical devices to healthcare professionals and institutions worldwide.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 11,740.412 mill.	$ 1,240.100 mill.	$ 42.233 mill.	39 mill.	285.76	Y/Y 16.32 %

Market Cap.	Revenues TTM	Net Income TTM
$ 11,740.412 mill.	$ 1,240.100 mill.	$ 42.233 mill.
Employees	Shares Outstanding	P/E
4,200	39 mill.	285.76
Revenue Growth	Income Growth
MRQ Y/Y 16.32 %	MRQ Y/Y 256.51 %